Radioimaging of lymph node involvement in prostatic carcinoma

Area of Science:

• Oncology
• Nuclear Medicine
• Immunology

Background:

• Prostate cancer diagnosis and staging are critical for treatment planning.
• Current staging methods have limitations in detecting lymph node involvement.
• Monoclonal antibodies targeting prostatic acid phosphatase offer a potential diagnostic avenue.

Purpose of the Study:

• To evaluate the utility of radiolabeled monoclonal antibodies against prostatic acid phosphatase for preoperative staging of prostate cancer.
• To assess the technique's ability to detect lymph node metastases prior to radical prostatectomy.

Main Methods:

• Seven patients eligible for radical prostatectomy and two with bone metastases received bilateral periprostatic injections of 1 mg of monoclonal antibodies.
• Gamma camera imaging was performed to detect radiolabeled antibody uptake.
• Findings were correlated with surgical staging pelvic lymphadenectomy.

Main Results:

• Lymph node metastases were detected in one patient in the left para-aortic, iliac, and obturator regions.
• Radioimaging correctly identified the absence of lymph node metastases in four patients, confirmed surgically.
• The technique demonstrated sensitivity in detecting metastatic lesions.

Conclusions:

• Radiolabeled monoclonal antibodies against prostatic acid phosphatase, when injected periprostatic, show promise for preoperative staging of prostate cancer.
• This immunoscintigraphy approach may improve the detection of lymph node involvement.
• Further research is warranted to validate this technique in a larger cohort.